Skip to main content

Table 3 Results of Cox's multivariate regresssion analysis for BLI, HER status and known prognostic variables

From: Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling

Variables (n = 48)

p value

Grade

0.155

Size

0.008

Nodal status

0.283

ER status

0.197

BLI

0.052

HER1-3 status

0.003

HER4 status

0.985